Monomorphic Ventricular Tachycardia Due to Brugada Syndrome Successfully Treated by Hydroquinidine Therapy in a 3‐Year‐Old Child

Vincent Probst(Centre National de la Recherche Scientifique), Hervé Le Marec(Centre National de la Recherche Scientifique), Pierre Boisseau(Centre Hospitalier Universitaire de Nantes), V. Gournay(Nantes Université), Stéphane Evain(Inserm), Marie Allouis(Inserm), Jean‐Jacques Schott(Centre National de la Recherche Scientifique)
Journal of Cardiovascular Electrophysiology
November 29, 2005
10.1111/j.1540-8167.2005.00329.x
Cited by 50

Related Papers

HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies
|Heart Rhythm|2011|1.5k
Congenital Heart Disease Caused by Mutations in the Transcription Factor <i>NKX2-5</i>
|Science|1998|1.3k
Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death
|Nature|2003|961
HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)
|EP Europace|2011|904
Long-Term Prognosis of Patients Diagnosed With Brugada Syndrome
|Circulation|2010|850